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will break the barrier, making the 
TJ a frequent contributor to a vast 
range of pathologies of blood vessels 
and epithelial organs. Since most of 
these insults have pleotropic cellular 
effects, it is difficult to envision 
therapies that could target specific TJ 
components or functions. In contrast, 
some assaults on the barrier are quite 
specific. For example, house dust 
mites excrete a fecal protease that 
cleaves occludin and claudin, loosens 
the barrier and in theory allows 
allergens to cross the airway and skin 
epithelia. Similarly, some types of 
allergenic pollen produce a protease 
which cleaves occludin, enhancing 
allergen entry. Specific claudins are 
receptors for a cytotoxic diarrhea-
inducing enterotoxin produced by 
Clostridium perfringens and other 
claudins are co-receptors required for 
hepatitis C virus to enter cells.
The growing list of diseases caused 
by mutations in the genes encoding 
TJ proteins has provided significant 
insight into how the TJ works. For 
example, claudins 16 and 19 form 
cation-selective pores and are located 
in a segment of the kidney tubule 
where Mg2+ ions return to the body 
by passing through the TJ. Mutations 
in either protein are associated with 
a failure to reabsorb Mg2+, leading to 
low serum Mg2+ levels and resultant 
weakness and seizures. Loss of ion 
selectivity may also explain why 
claudin-14 mutations lead to deafness. 
Mutations in PMP-22, a claudin 
which seals myelin, lead to peripheral 
neuropathies through an unknown 
mechanism. Hopefully our increasing 
knowledge of TJ structure will lead 
to specific therapies to preserve or 
restore integrity of the barrier. 
Can we manipulate TJs to enhance 
drug delivery? In principle it might 
be desirable to open TJs in order to 
enhance drug delivery across epithelia 
like the gut and airway surfaces or 
across blood vessels like the blood–
brain barrier. Manipulation of the 
barrier may be required for the delivery 
of emerging therapeutic agents based 
on peptides, proteins and DNA. 
Despite wide interest and research, 
however, no agents have yet reached 
clinical application. Early efforts 
employed non-specific attacks on 
general signaling pathways that led to 
cells being pulled apart or alternatively 
used detergents to disrupt epithelial 
integrity. More recent approaches 
specifically target the intercellular 
interactions of claudins or occludin. 
Given the role of TJs in limiting drug 
delivery, there is a lot of creative 
energy applied to this problem; 
however, we will have to wait to see 
whether it’s a good idea to break the 
barrier even transiently. 
Is there a link between TJs and 
cancer? As a rule, cells use every 
point of cell–cell and cell–substrate 
contact to transfer information. 
Although we do not yet know 
what information the cell receives 
at TJs, the importance of TJs for 
differentiation and proliferation is 
suggested by the frequent alteration 
in claudin profiles seen in specific 
cancers. During 2007 alone there 
were >60 publications on PubMed 
using different claudins to classify 
and even to prognosticate outcome in 
various human carcinomas. Beyond 
these correlations, there are a few 
papers that report the manipulations 
of claudin levels in human cancer 
cell lines and show a correlation with 
metastatic potential when injected 
into mice. A link to Wnt signaling has 
also been implicated. The massive 
overexpression of specific claudins 
in specific cancers has led to several 
proof-of-principle studies targeting 
those claudins for chemotherapy. 
Specifically, in mouse models, the 
previously mentioned C. perfringens 
toxin will effectively eliminate human 
ovarian and pancreatic cancers, 
which overexpress the toxin receptors
claudins 3 and 4. However, much 
remains to be learnt before TJ 
signaling can be targeted for cancer 
therapy.
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Wnt–β-catenin 
signaling 
Ken M. Cadigan
Wnts are a family of extracellular 
cell–cell signaling molecules which 
act in a wide range of developmental 
processes in metazoans; the 
name derives from the Drosophila 
gene Wingless, and the related 
mammalian oncogene Int-1.  
No-one knows for sure when the 
first Wnt evolved, but the existence 
of fourteen Wnt genes in the sea 
anemone Nematostella vectensis — 
by comparison, there are seven Wnts 
in Drosophila, five in Caenorhabditis 
elegans and nineteen in mice and 
humans — indicates that this gene 
family had already evolved and 
diversified more than 600 million 
years ago. Wnts are proteins defined 
by a conserved primary sequence 
that includes twenty-one specifically 
spaced cysteines. The expression 
pattern of the sea anemone Wnts 
suggests that they form a ‘Wnt-
code’ that specifies its basic body 
plan and recent functional studies 
indicate that Wnts are required 
for primary and axial patterning 
in several cnidarian species. For 
the metazoan species that have 
been exploited by developmental 
biologists for their ease of genetic 
analysis, such as flies, worms and 
mice, there is abundant evidence 
that many developmental decisions 
are controlled by Wnts, from 
gastrulation and early pattern 
formation to organogenesis. 
Although Wnts are known to 
influence cell behavior through 
several different signaling pathways, 
many act by regulating the stability 
and subcellular localization of 
β- catenin. This intensively studied 
signal cascade is known as the 
Wnt–β-catenin pathway, the focus  
of this primer.
While the Wnt–β-catenin 
pathway is often thought of as a 
major signaling pathway in animal 
development, it also plays important 
roles in stem cell maintenance 
in regenerating tissues such 
as intestinal epithelia and hair 
follicles. Wnt–β-catenin signaling 
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regeneration and wound repair. 
This may reflect an ancient role 
for Wnts, as pathway activation is 
required for regeneration of the head 
organizer of hydra, a freshwater 
cnidarian. In addition to its essential 
functions in development and tissue 
homeostasis, misregulation of 
Wnt–β-catenin signaling has been 
implicated in several pathological 
states. Constitutive activation of the 
pathway has been linked to several 
human cancers. Wnt–β-catenin 
signaling in vertebrates promotes 
bone disposition, and mutations that 
reduce signaling can result in fragile 
bones. This pathway has also been 
implicated in other diseases such 
as heart disease and Alzheimer’s, 
though further validation of these 
reports is needed. This primer 
provides an overview of how Wnts 
are released from producing cells 
and how they signal from the cell 
surface to the nucleus of receiving 
cells.
Wnt secretion and extracellular 
movement
Wnts contain signal sequences 
at their amino-termini that target 
them to the endomembrane/
secretory compartment. Like many 
secreted proteins, they are subject 
to amino-linked glycosylation in 
the endoplasmic reticulum (ER). 
Furthermore, many Wnts have been 
shown to be palmitoylated at the 
first conserved cysteine; palmitoylic 
acid can also be covalently linked 
to a conserved serine in some Wnts. 
The function of Wnt lipidation is 
somewhat controversial, though this 
is likely due to differences in the 
chosen Wnt and species, and the 
methodology used to study them. In 
cell culture, Wnts lacking cysteine 
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Figure 1. Wnt secretion. 
Wnt is palmitoylated by the Porc acyltransferase, which may facilitate its exit from the ER. In 
the trans-Golgi, Wls directs Wnt to the cell surface where it can associate with extracellular 
molecules such as glypicans or lipoproteins. Wls recycling back to the Golgi requires the retro-
mer complex; in the absence of Retromer, Wls is missorted to the lysosomes and degraded.palmitolyation are secreted but 
not functional, while in fly embryos 
a corresponding mutation of the 
Wingless gene causes a block in 
secretion of the encoded protein 
and likely accumulation in the 
ER. Consistent with these results, 
mutations in the porcupine (porc) 
gene, which encodes an integral 
membrane acyltransferase localized 
to the ER, blocks secretion of Wg. 
This suggests a model in which 
modification by Porc is required 
for export of Wnt from the ER 
(Figure 1). In the case of palmitoleic 
acid, prevention of the modification 
inhibits either secretion or signaling 
activity of Wnt, depending on the 
system and Wnt tested. 
After post-translational 
modification, several Wnts require 
an integral membrane protein called 
Wntless (Wls) for secretion. Wls is 
localized to the Golgi, cell surface 
and endosomes and appears to be 
dedicated to Wnt secretion. Wls 
can directly associate with Wnt, 
suggesting that it acts to guide Wnt 
from the Golgi to the cell surface. 
Recycling of Wls from the plasma 
membrane requires the activity of 
the retromer complex: mutation of 
retromer subunits results in reduced 
levels of Wls protein and Wnt 
signaling as a result of mistrafficking 
of Wls to the lysosome (Figure 1).
Given the complexity of Wnt 
modification and secretion, it is 
not surprising that large quantities 
of biologically active, soluble Wnt 
have been so notoriously difficult to 
obtain through standard expression 
in cultured cells. It would also not be 
surprising to find that the efficiency 
of Wnt secretion and/or activity is 
being modulated by regulation of 
acyltransferase and/or Wls activity. 
That said, this system may not be 
required for the entire Wnt family, 
as a recent report found that one 
fly Wnt is not lipidated and does 
not require either porc or Wls for 
secretion and activity. 
Once outside of the producing 
cell, Wnts become associated 
with the surface of cells and the 
extracellular matrix. Glypicans, one 
type of cell surface proteoglycan, 
are required for Wnt signaling in fly 
tissues. Glypicans are known to act 
as co-receptors in FGF signaling 
and there is evidence supporting 
a similar role in Wnt signaling. 
Glypicans also promote the spread 
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Wnts can act as morphogens, 
directly regulating distinct target 
genes in a concentration-dependent 
manner, and glypicans can 
profoundly influence the shape of 
the Wnt morphogen gradient. In fly 
tissues, extracellular Wnts can  
also associate with lipoprotein 
complexes that facilitate their 
diffusion (Figure 1). 
Wnt-induced stabilization of 
β- catenin
The Wnt–β-catenin pathway revolves 
around the stability of β-catenin, 
with higher levels of this protein 
promoting activation of Wnt targets. 
β-catenin is also essential for cell 
adhesion, forming a link between  
E-cadherin and the actin 
cytoskeleton. In addition to this 
membrane-bound pool of β- catenin, 
there is a cytoplasmic pool that 
rapidly turns over in unstimulated 
cells. It is this β-catenin pool that 
is regulated by Wnt stimulation, 
although there is evidence for a 
more dynamic interaction between 
cytosolic and membrane-bound 
β-catenin in some cells, suggesting 
a direct link between Wnt–β-catenin 
signaling and cell adhesion.
Degradation of β-catenin 
is triggered by a dual kinase 
mechanism, where phosphorylation 
of a particular serine by 
casein kinase I (CKI) leads to 
phosphorylation of several other 
serine/threonines by glycogen 
synthase kinase 3 (GSK3). This 
modified β-catenin is then bound 
by the F-box-containing ubiquitin 
E3 ligase β-TrCP, triggering 
poly- ubiquitination and proteosomal 
degradation of β-catenin (Figure 2A). 
As a result, β-catenin not bound to 
cadherin has an average half-life of 
approximately 30 minutes in the cell. 
For β-catenin to be 
phosphorylated by CKI and GSK3, 
it must be bound by a complex 
containing two other factors, the 
adenomatous polyposis coli (APC) 
protein and Axin (Figure 2A). These 
large proteins appear to act as 
scaffolds, positioning β-catenin 
and the kinases to allow efficient 
phosphorylation. These proteins 
cycle between the cytoplasmic and 
nuclear compartments and act to 
prevent accumulation of β-catenin 
in the nucleus. The associated 
APC–Axin–CKI–GSK3 proteins are often referred to as the β-catenin 
destruction complex. Consistent 
with the proposed role of the 
destruction complex, mutation 
of either APC or Axin results in 
dramatically elevated levels of 
β-catenin in both the cytoplasm 
and nucleus. A similar effect is 
observed when the CKI or GSK3 
phosphorylation sites in β- catenin 
are mutated. 
The study of β-catenin turnover 
is a prime example of the interplay 
between clinical and basic research. 
The APC gene was first identified 
as the target for a familial form 
of colorectal cancer: sporadic 
mutation of APC activity occurs in 
approximately 90% of all human 
colorectal cancers. After APC 
function was linked to β-catenin 
turnover, studying this process in 
model systems — Xenopus and 
Drosophila — revealed that CKI and 
GSK3 phosphorylate the amino-
terminus of β-catenin. Examination 
of colorectal cancers with  
wild-type APC genes revealed that 
many have mutations in the CKI 
or GSK3 phosphorylation sites of 
β-catenin: up to 20% of all human 
cancers contain these specific 
mutations. Our basic understanding 
of Wnt–β-catenin signaling has 
been advanced by the study of 
a particular human cancer, while 
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Figure 2. Regulation of β-catenin stability by Wnt signaling. 
The illustration depicts a cell in the absense (A) or presence (B) of Wnt. In unstimulated cells, 
β-catenin not complexed with the cadherin adhesion complex is phosphorylated by CKI and 
GSK3, part of the destruction complex, leading to β-TrCP dependent ubiquitination and pro-
teosomal degradation. The presense of Wnt promotes LRP and Fz association, leading to 
recruitment of Dvl to the complex and GSK3 and CKI phosphorylation of LRP. This stabilizes 
recruitment of Axin to the receptor which may disrupt the activity of the destruction complex, 
which allows accumulation of β-catenin and nuclear translocation. See text for details.
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biochemical mechanism has led to 
the recognition that this pathway 
plays a major role in many human 
cancers.
For cells to stabilize β-catenin 
in response to extracellular Wnt 
protein, they must have specific 
cell surface receptors that can bind 
to Wnt with high affinity as well as 
transduce the signal across the cell 
membrane. While the number of 
identified potential Wnt receptors 
is growing, it is also clear that most 
Wnt–β-catenin signaling occurs 
through an unlikely pairing of 
members of two distinct receptor 
families: Frizzleds (Fzs) and two 
members of the lipoprotein receptor 
related protein (LRP) family, LRP5 
and LRP6. Fzs are members of the 
larger family of seven-membrane 
spanning G-protein-coupled 
receptors that mediate a wide variety 
of signaling events; this family 
includes the olfactory receptors, 
for example. LRPs include the low 
density lipoprotein receptor. The 
current model is that the Wnt ligand 
promotes association of Fz and 
LRP5/6, and this close association 
leads to activation of the receptor 
complex. 
Wnt-dependent coupling of Fz 
and LRP5/6 is reminiscent of the 
ligand-induced dimerization and 
subsequent trans-phosphorylation 
that occurs with tyrosine kinase 
or TGF-β receptors, except that 
neither Fz or LRP5/6 has any known 
enzymatic activity. Wnt binding does, 
however, induce phosphorylation 
of the cytoplasmic tail of LRP5/6, 
and this modification is required 
for β- catenin stabilization. 
Interestingly, this phosphorylation 
of LRP is mediated by CKI and 
GSK3, the same kinases that act in 
the destruction complex to target 
β-catenin for degradation. There is 
some debate about which specific 
CKI family members act on LRP and 
β-catenin, but the CKI–GSK dual 
phosphorylation mechanism has 
both a positive (LRP) and negative 
(β-catenin) effect on Wnt signaling.
The exact details of receptor 
complex activation and LRP 
phosphorylation are still under 
investigation, but it appears that 
several factors act in a mutally-
dependent manner to facilitate 
the process. LRP phosphorylation 
requires the co-receptor Fz, which is bound by PDZ-containing 
proteins called Dishevelleds 
(Dvls) upon Wnt stimulation. Dvls 
promote LRP phosphorylation 
and Axin recruitment to the 
plasma membrane. However, Axin 
recruitment is not sequential to these 
events, because this protein is also 
required for LRP phosphorylation. 
These data suggest a model in 
which these factors all contribute 
to the formation of an active-LRP 
phosphorylated complex. Indeed, 
there is also compelling evidence 
that LRP and Dvl form higher-order 
complexes upon Wnt stimulation, 
suggesting the existence of an even 
larger Wnt signalosome at the cell 
surface (Figure 2B). 
The recruitment of Axin to the 
phosphorylated tail of LRP5/6 may 
promote β-catenin stabilization by 
compromising the activity of the 
destruction complex as well as 
promoting Axin degradation. But 
this may not be the whole story. 
Consistent with Fzs being members 
of the G-protein coupled receptor 
superfamily, Gαo and Gαq subunits 
are required for Wnt–β-catenin 
signaling, and locking these proteins 
in the GTP-bound state promotes 
pathway activation. However, direct 
evidence for a physical link between 
Fz and Gαo/q is lacking and the 
target(s) of the activated G-protein 
is still mysterious, though Dvls are 
attractive candidates perhaps by 
promoting their phosphorylation 
(Figure 2).
The Wnt–β-catenin pathway is a 
prime example of how regulation of 
protein turnover can modulate cell 
signaling. By relying on stabilization 
of β-catenin, this branch of Wnt 
signaling by necessity acts over 
the course of hours, as opposed 
to minutes. This is in contrast to 
pathways that do not require new 
protein synthesis to operate. Thus, 
the Wnt–β-catenin pathway is 
very often found in contexts such 
as cell-fate determination and 
tissue homeostasis, as opposed to 
situations where more immediate 
regulation of gene expression 
is required, for example stress 
responses. 
A transcriptional switch
After stabilization, β-catenin 
translocates across the nuclear 
pore complex to the nucleoplasm. 
It is thought that this is an intrinsic property of β-catenin, although there 
are several factors that can influence 
its nuclear import or export. Once in 
the nucleus, β-catenin can act as a 
transcriptional co-regulator, binding 
to specific DNA-binding transcription 
factors. Although the list of proteins 
known to recruit β-catenin to target 
genes is growing — Foxo, PitX2, 
SOX9 and SOX17, for example — 
most cases of Wnt-mediated 
transcriptional regulation involve 
members of the TCF protein family.
While the interaction of β-catenin 
and TCF is critical for activation of 
Wnt targets, it is also critical that 
these targets are not activated 
inappropriately by small amounts of 
nuclear β-catenin. Several different 
factors have been identified that act 
as nuclear β-catenin buffers — they 
compete with the β-catenin–TCF 
interaction by binding to either 
factor. ICAT, Chibby, Sox9 and CtBP-
APC are among the factors that bind 
to β-catenin and inhibit it binding 
to TCF. Members of the TLE/Gro 
family do the same for TCFs (Figure 
3A). These nuclear factors raise 
the threshold of nuclear β-catenin 
required for its recruitment to Wnt 
targets via binding to TCF.
In the absence of signaling, 
many Wnt targets are silenced 
by TCF- mediated repression. 
This occurs in part through TCF 
binding to TLE/Gro, which in turn 
recruits histone deacetylases 
(Figure 3A). Other factors have also 
been implicated in silencing Wnt 
targets — for example, Kaiso and 
the chromatin remodeling complex 
ACF — though these act in parallel 
to TCF–TLE/Gro and do not function 
on all targets. 
When β-catenin reaches levels 
sufficient to bind to TCF, this 
interaction displaces TLE/Gro 
from Wnt target genes, relieving 
repression. In addition, β-catenin 
serves as a landing platform 
for a variety of transcriptional 
co- activators. These include 
Legless/Bcl9 and Pygopus (Pygo) 
which bind to the amino-terminal half 
of β-catenin, while the histone acetyl 
transferase CBP and Parafibromin/
Hyrax bind to the carboxy-terminal 
portion. There are many other 
co- activators that bind to β-catenin 
and promote its ability to activate 
Wnt target genes; however, many 
of these factors are likely to be 
gene, cell-type or species-specific. 
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Perceptual 
mislocalization of 
bouncing balls by 
professional tennis 
referees
David Whitney, Nicole Wurnitsch, 
Byron Hontiveros and  
Elizabeth Louie
The perceived position of a moving 
object depends on the object’s 
motion and the motion of other 
objects in the scene [1]. Here, we 
report a real-world example of 
how this causes a perceptual error 
for professional tennis referees, 
which players could exploit to their 
advantage.
A relatively new rule in 
professional tennis allows players 
to challenge referee calls. As long 
as the player continues to challenge 
incorrect referee calls, the player 
is allowed to continue making 
challenges. In the 2007 Wimbledon 
championship, there were over 140 
player challenges, and more than 
25% of these resulted in overturned 
calls. Clearly, challenges make a 
difference in the outcome of tennis 
matches. Successfully challenging 
calls allows players to continue 
making challenges, and it therefore 
behooves players to challenge only 
those calls that they believe are 
clearly in error.
Although it is well known that 
moving objects are misperceived as 
being shifted in the direction of their 
motion ([2,3]; see also Supplemental 
References in the Supplemental Data 
available online with this issue), these 
kinds of perceptual errors have rarely 
been documented in sports [4–6]. To 
measure whether referees accurately 
perceive the position at which a 
tennis ball bounces, we reviewed 
randomly selected Wimbledon tennis 
matches (4,457 total points) and 
recorded each case in which a tennis 
ball landed close to or on a line 
(Figure 1; see also the Supplemental 
Experimental Procedures). On each 
recorded trial (point), three trained 
observers independently rated 
whether the ball landed on or off the 
CorrespondencesIndeed, while pygo is essential for 
Wnt regulation of targets in flies, 
mice lacking both pygo genes have 
a much more modest reduction in 
Wnt target gene expression. At the 
general level, however, the idea 
that β-catenin switches a TCF from 
a transcriptional repressor to an 
activator is a useful way to think of 
Wnt-mediated regulation of many 
target genes. While invertebrate 
TCFs clearly contain both the 
repressive and activating activities — 
essential in flies and worms which 
only have one TCF each — it appears 
that some vertebrate TCFs have 
become more specialized, with 
TCF3 possessing mainly silencing 
activity and LEF1 functioning 
in the activation portion of the 
transcriptional switch. 
It should be noted that there are 
many genes that are downregulated 
in response to Wnt signaling, 
and in some cases it has been 
confirmed that a TCF–β-catenin 
complex directly mediates this 
repression. How many of the genes 
downregulated by Wnt–β-catenin 
signaling are directly repressed 
remains an important unanswered 
question. The mechanism of TCF– 
β-catenin repression has not been 
worked out in detail, and it appears 
to be different among the few genes 
studied in detail. The diversity of 
mechanisms by which β- catenin 
can regulate gene expression likely 
explains how this pathway can 
perform so many essential functions 
throughout the animal kingdom. 
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Figure 3. The TCF transcriptional switch mediating activation of Wnt targets. 
In the absence of signaling (A), TCF represses Wnt targets by recruiting co-repressors such 
as TLE/Gro. Other repressive complexes also contribute to this silencing. In addition, there are 
several factors that act as ‘nuclear β-catenin buffers’ which prevent β-catenin–TCF interac-
tion when β-catenin is present at low concentrations. On Wnt signaling (B), the high level of 
nuclear β-catenin overcomes these buffers, and β-catenin displaces the repressors from the 
target gene chromatin. β-catenin dependent recruitment of a variety of co-activators allows 
transcription to proceed.
